Latest News Archive
Please select Category, Year, and then Month to display items
05 April 2021
|
Story Dr Nitha Ramnath
|
Photo Supplied
Jamba Isaac Ulengo.
François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series. Intended to reconnect alumni with the university
and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021. Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate
why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate
the diversity and touchpoints that unite them.
Our podcast guest
Born in the North West town of Vryburg, Ulengo first played provincial rugby at the U16 Grant Khomo Week in 2005. While attending Jim Fouché High School in Bloemfontein, Ulengo was chosen to represent the Free State at various youth levels. As
an up-and-coming player, Ulengo made his break via the FNB Varsity Cup Competition where he starred for the Shimlas, scoring 11 tries in 18 appearances over the three seasons between 2010 and 2012. A short stint with the Free State Vodacom Cup side
saw him make his debut for the Blitzboks (Glasgow 2012), followed by a tournament at the London Sevens in 2014. Ulengo has been a prominent member of the South African Sevens since making his debut for the team in the Scotland leg of the 2011-2012
IRB Sevens World Series. He played in the two final tournaments of that season and then signed a two-year contract with the South African Rugby Union to represent the team in the 2012-2013 and 2013-2014 series. While he only competed at four events
in his first full season, he was involved in seven of the tournaments in his second season.
Ulengo made his return to the sport by signing a contract to play Currie Cup rugby for the Pretoria-based Blue Bulls in 2014 and for their Super Rugby franchise, the Bulls, from the 2015 Super Rugby season.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004